Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatients-Reference-Cited by-同舟云学术

Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatients

Published:2019-01 Issue:1 Volume:118 Page:109-115
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Khan Qasim,Ismail Mohammad^ORCID,Haider Iqbal,Ali Zahid

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Prevention of Torsade de Pointes in Hospital Settings

2. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study;Dekker;J Am Coll Cardiol,2004

3. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population;Schouten;Circulation,1991

4. The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products;Committee for Proprietary Medicinal Products,1997

5. Long QT syndrome: diagnosis and management;Khan;Am Heart J,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential drug-drug interactions in outpatients with depression of a psychiatry department;Saudi Pharmaceutical Journal;2023-02

2. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients;Cardiovascular Drugs and Therapy;2023-01-10

3. Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database;In Vivo;2023

4. The association between proton pump inhibitor prescription and QT interval prolongation in intensive care unit patients;2022-11-14

5. Ventricular tachycardia triggered by the first dose of an adenoviral vector‐based COVID‐19 vaccine in an adult patient with congenital heart disease;Clinical Case Reports;2022-09